Vivek Hattangadi

My Neurons Will Atrophy if I Stay in the Pharmaceutical Industry – Brand Management 131

My Neurons Will Atrophy if I Stay in the Pharmaceutical Industry – Brand Management 131 When Veekas Sabnis, a bright B-school graduate in Pharmaceutical Management and my mentee, decided to leave the pharmaceutical industry after three and a half years as a brand manager, many were surprised. He had a promising career ahead. But Veekas

My Neurons Will Atrophy if I Stay in the Pharmaceutical Industry – Brand Management 131 Read More »

What’s in a Name? A Rose by Any Name Would Smell as Sweet – Brand Management 128

What’s in a Name? A Rose by Any Name Would Smell as Sweet – Brand Management 128 What’s in a Name? Case Study It was 18th August 1992, when we at Intas decided to launch cisapride, a gastric prokinetic. We were not the first. Unipride (Torrent), Esorid (Sun),  Santiza (Cadila), Cisade (Unichem) – all formidable

What’s in a Name? A Rose by Any Name Would Smell as Sweet – Brand Management 128 Read More »

Patient-centricity and People-centricity – The Two Sides of the Same Coin!

Patient-centricity and People-centricity – The Two Sides of the Same Coin! – Brand Management 127 Sanjeev Navangul with over 30 years of experience in the pharma industry has successfully implemented quite a few patient centric programs. He commenced his address with the most famous words of George Merck: “For the medical and pharmaceutical community to be

Patient-centricity and People-centricity – The Two Sides of the Same Coin! Read More »

Patients Are Not Widgets: They Are Our Consumers – Brand Management 126

Patients Are Not Widgets: They Are Our Consumers – Brand Management 126 Who really are the customers for pharma? Some time back, I was reading an article ‘MIND YOUR LANGUAGE TO CATALYSE THE PATIENT REVOLUTION’ from the British Medical Journal (BMJ). It expressed deep concern for the patients. “The voices of patients and citizens were

Patients Are Not Widgets: They Are Our Consumers – Brand Management 126 Read More »

Pharma India’s Growth Puzzle: Before Asking “Where Are We Going?”, Ask “Why Are We Here Today?”

Pharma India’s Growth Puzzle: Before Asking “Where Are We Going?”, Ask “Why Are We Here Today?” I just went through the PharmaTrac report for May. A few observations came to mind. 1. Value growth continues to outpace volume growth At the overall IPM level, MAT growth stands at 9.0% in value terms, while unit growth

Pharma India’s Growth Puzzle: Before Asking “Where Are We Going?”, Ask “Why Are We Here Today?” Read More »

Responsibilities and Accountability at Different Levels in the Hierarchy of Brand Management Teams – Brand Management 125

Responsibilities and Accountability at Different Levels in the Hierarchy of Brand Management Teams – Brand Management 125 Case Study V & V Pharmaceuticals was a family owned organization, but was growing rapidly because of people who were in this company since its inception. They were fiercely loyal to V & V. As the company progressed,

Responsibilities and Accountability at Different Levels in the Hierarchy of Brand Management Teams – Brand Management 125 Read More »